How Can Photodynamic Therapy Challenge Microbial Resistance of Localized Infections?
JUL 07, 2017 | CONTAGION® EDITORIAL STAFF
Caetano P. Sabino, BSc, PhD Student, Clinical Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, explains how photodynamic therapy can be used to challenge microbial resistance of localized infections.
Interview Transcript (slightly modified for readability)
“It’s really questionable whether any resistance can be developed against photodynamic therapy; as long as we are not selecting those drug-resistant bugs in the wounds anymore through chemotherapy, we are just killing them all in the same pattern. We are just living behind the drug-resistant selection and spread, and if we could also manage the dissemination of drug-resistant genes through plasmids, we can end up with dissemination of cross-interaction in between bacteria [and] the spread of drug-resistant genes. We are just blocking the thing in the beginning.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512